The estimated national prevalence of non-celiac gluten sensitivity is 0.548%, approximately half that of celiac disease. Future studies are merited in order to better understand the population burden of non-celiac gluten sensitivity.
Goals
To determine whether patients with celiac disease and low vitamin D levels also have a higher prevalence of other autoimmune diseases (AD) as compared to patients with normal vitamin D levels.
Background
Patients with CD carry a higher risk of other autoimmune disorders. Because of its immunoregulatory properties, vitamin D deficiency has been proposed in the pathogenesis of a variety of AD. Whether low vitamin D levels in patients with CD can predict concomitant AD is unknown.
Study
A retrospective cross-sectional study of 530 adult patients with CD and a 25-hydroxyvitamin D level on record at CUMC.
Results
133 patients (25%) had vitamin D deficiency. The prevalence of AD was similar among those with normal vitamin D (11%), insufficiency (9%), and deficiency (12%, p=0.66). On multivariate analysis, adjusting for age of CD diagnosis and gender, vitamin D deficiency was not associated with AD (OR 1.35 95% CI 0.62–2.95). The risk of psoriasis was higher in patients with vitamin D deficiency (7% vs. 3%, p=0.04). Vitamin D deficiency was more common in those who presented with anemia (39%) than in those who did not (23% p=0.002).
Conclusion
Vitamin D deficiency in CD is common but does not predict AD. Psoriasis is increased in vitamin D deficient CD patients. Assessment of vitamin D appears to be a high-yield practice, especially in those CD patients who present with anemia.
The proportion of individuals HLA DQ2/8 positive is higher in those with liver/upper functional GI disease and lower in IBS/IBD as compared to general population estimates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.